Visit the iAnthus Capital Holdings Investor Dashboard and stay up to date with data-driven, fact based due diligence for active traders and investors.
iAnthus Capital Holdings, Inc. Announces Notice of Redemption of Debentures
NEW YORK and TORONTO, March 25, 2019 /PRNewswire/ – iAnthus Capital Holdings, Inc. (“iAnthus” or the “Company”) (CSE: IAN, OTCQX: ITHUF) announces that, as of March 22, it has issued a notice of redemption to holders of outstanding convertible debentures of MPX Luxembourg SARL, a wholly-owned subsidiary of iAnthus, in the aggregate principal amount of US$32,257,804.07 (the “Debentures”). As set out in the notice of redemption, the redemption date of the Debentures will be April 24, 2019 (the “Redemption Date”). The Debentures are redeemable for an amount (the “Redemption Price”) equal to US$860.43 per US$1,000 principal amount of Debentures, being the Redemption Price prescribed as of the Redemption Date pursuant to the terms of the debenture indenture (as amended or supplemented from time to time, the “Debenture Indenture”) governing such Debentures.
The MPX Luxembourg convertible debentures were a legacy obligation inherited by iAnthus as part of the acquisition of MPX Bioceutical Corp. The redemption or resulting conversion of these debentures will enable us to significantly reduce our interest expense and potential further future dilution for our shareholders.
Hadley Ford, Chief Executive Officer of iAnthus
The removal of this expensive debenture is a key part of our commitment to optimizing our cost of capital. Given that the holders of the debentures are significantly in the money, it is our expectation that the vast majority of holders will convert, as opposed to redeem their notes.
Prior to the redemption of the Debentures, each holder thereof will have the right to convert the Accrued Principal Amount (as defined in the Debenture Indenture) of their Debentures into units of iAnthus (“Units”), each such unit consisting of 0.1673 of one common share in the capital of iAnthus (each whole common share, an “iAnthus Share”) and 0.08365 of one common share purchase warrant (each whole warrant, an “iAnthus Warrant”) (based on the exchange ratio of 0.1673 iAnthus Shares for each common share of MPX Bioceutical Corporation (“MPX”) in connection with iAnthus’ recently completed acquisition of MPX pursuant to a court approved plan of arrangement), at a conversion price equal to $0.74 per Unit at any time prior to close of business on April 23, 2019. A holder electing to convert their Debentures will receive 1,729.80 Units (representing 289 iAnthus Shares and 144.5 iAnthus Warrants) for each US$1,000 of Accrued Principal Amount. No fractional iAnthus Shares or iAnthus Warrants (other than in integrals of one-half Warrants) will be issued on conversion.
All holders of Debentures who fail to deliver a notice of conversion on or prior to April 23, 2019 shall have their Debenture redeemed on the Redemption Date and shall receive their pro rata portion of the Redemption Price.
As of the date hereof, the Units to be issued on conversion of the Debentures are heavily “in the money”. Accordingly, the Company believes that the vast majority of the holders of Debenture will elect to convert their Debentures prior to April 23, 2019.
About iAnthus Capital Holdings, Inc.
iAnthus Capital Holdings, Inc. owns and operates best-in-class licensed cannabis cultivation, processing and dispensary facilities throughout the United States, providing investors diversified exposure to the U.S. regulated cannabis industry. Founded by entrepreneurs with decades of experience in operations, investment banking, corporate finance, law and health care services, iAnthus provides a unique combination of capital and hands-on operating and management expertise. iAnthus currently has operations in 11 states, and operates 21 dispensaries (AZ-4, MA-1, MD-3, FL-3, NY-2, CO-1, VT-1 and NM-6 where iAnthus has minority ownership). For more information, visit www.iAnthusCapital.com.
For fact-based information on iAnthus Capital Holdings, view the company’s sponsored Investor Dashboard.
Get ahead of the crowd by signing up for 420 Investor, the largest & most comprehensive premium subscription service for cannabis traders and investors since 2013.